Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants.

By M. Clara, B. Strenn, O. Gans, E. Martínez, N. Kreuzinger, H. Kroiss. Water Research, 2005

1,001 citations recorded by the source corpus.

Subfields: Environmental Chemistry, Health, Toxicology and Mutagenesis, Pollution

View Paper: https://www.semanticscholar.org/paper/211db8c5772cd908ef1f6f3f76947184230d8aed

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Environmental Chemistry

In Health, Toxicology and Mutagenesis

In Pollution

Citations in the corpus

From the conventional biological wastewater treatment to hybrid processes, the evaluation of organic micropollutant removal: A review. (2017, methodology): “Among the PPCPs and some of their human metabolites, ACE, CFN, digox-igenin, E1, IBP, NPX, and paraxanthine are for instance rather well removed ( > 90%); whereas CBZ, EDTA, MFA, gem ﬁ brozil (GFZ), CIP, E3, o ﬂ oxacin (OFX), penicillin V, SMX, TMP are poorly removed from in ﬂ uent (Bernhard et al.,”
Urban wastewater treatment plants as hotspots for the release of antibiotics in the environment: a review. (2013, background): “Clara et al., 2005 500 500 (0”
Pharmaceuticals as emerging contaminants and their removal from water. A review. (2013, background): “There have been various reports that carbamazepine is not appreciably removed by WWTPs (Ternes, 1998; Heberer, 2002a; Strenn et al., 2004; Clara et al., 2005).”
A national reconnaissance for pharmaceuticals and other organic wastewater contaminants in the United States--II) untreated drinking water sources. (2008, background): “Although wastewater treatment plant effluents are only one potential source, human and animal wastewater effluents are among the most important associated source pathways for the majority of these compounds into the aquatic environment (Clara et al., 2005; Glassmeyer et al., 2005; Lindqvist et al., ”
Degradation of selected pharmaceutical and personal care products (PPCPs) by white-rot fungi (2011, background): “tants (Carballa et al. 2005; Clara et al. 2005; Esplugas et al. 2007; Ikehata et al. 2006; Reif et al. 2008; Suárez et al. 2005; Von-Gunten et al. 2006).”
Antibiotics in the aquatic environments: A review of the European scenario. (2016, background): “…ranged from tens to hundreds ng L−1, which can be related to the low consumption of these agents in the community sector (Bendz et al., 2005; Clara et al., 2005; Lindberg et al., 2005; Hordern et al., 2009; Galán et al., 2010a; Rosal et al., 2010; Zuccato et al., 2010; Gros et al., 2013;…”
EU-wide monitoring survey on emerging polar organic contaminants in wastewater treatment plant effluents. (2013, background): “Carbamazepine and sulfamethoxazole are almost completely persistent during activated sludge treatment (Clara et al., 2005; Lindqvist et al., 2005; Hollender et al., 2009; Joss et al., 2006; Michael et al., 2013; Radjenovi c et al., 2007a).”
Occurrence and removal of antibiotics, hormones and several other pharmaceuticals in wastewater treatment plants of the largest industrial city of Korea. (2011, background): “Clara et al. (2005) have reported a decrease in ibuprofen concentration by 99% during the biological treatment in the WWTP.”
Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment--a review. (2012, methodology): “No reasonable justification for the increasing of iopromide concentrations within the WWTP could be identified, according to Clara et al. (2005b).”